Summary
-
1.
104,697 BCG vaccinations are analysed. 4,112 of these persons were contacts. The period covers four years.
-
2.
The over-all conversion rate was 97·25 per cent.
-
3.
The duration of immunity is discussed.
-
4.
Undesirable reactions numbered 16 (0·011 per cent.).
-
5.
Tuberculous disease developed in 10 immunised individuals (0·0071 per cent.) with 1 death. Eleven further cases occurred in persons who were incubating tuberculous disease about the time of vaccination (0·0078 per cent.) with 4 deaths.
-
6.
The vaccine, tuberculin tests, and technique employed are described.
Similar content being viewed by others
References
Edwards and Tolderlund (1952).Bulletin of W. H. O. on BCG-vaccine studies.
Edwards, Palmer and Magnus (1953).H. O. Monograph on BCG Vaccination,
Wallgren, Arvid (1950).Tuberculosis and other Problems of Paediatrics. Williams and Wilkins.
Price, D. S. (1952).Irish Jo. Med. Sci., No. 314, p. 88.
Report of National BCG Committee for the year ending December, 1952.
Anderson, H. and Belfrage, H. (1939).Acta Paed., 26.
Enell, H. (1951).Nordisk Medicin, 46, 1072.
Cowell, J. St. P. (1952).Irish Jo. Med. Sci., Nos. 320–21, p. 370.
Palmer, E. C. and Edwards, P. Q. (1953).B.M.J. i, 363.
Wallgren, Arvid (1947).Calmette- Vaccination in Sweden. Published by the Swedish National Anti-Tuberculosis Association.
Rights and permissions
About this article
Cite this article
Price, D.S. Analysis of BCG vaccinations. Ir J Med Sci 29, 56–64 (1954). https://doi.org/10.1007/BF02952867
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02952867